KALAMAZOO, Mich. (Great Lakes News) – Pfizer and BioNTech announced Monday that a smaller dose of its COVID-19 vaccine works to develop antibodies for kids ages 5 to 11.

Pfizer officials say two doses given three weeks apart had a similar effect to the dosage for people ages 16-25 years of age.

MORE NEWS: Former High School Soccer Ref Faces Assault Charges After Alleged Scuffle with Teen Player

In addition, the side effects are roughly the same.  Pfizer plans to submit this information to regulators soon.

Clinical data for children as young as six-months-old could be available sometime this fall.